HOME >> BIOLOGY >> NEWS
Cranfield collaborator receives multi million dollar financing

Cranfield University has been at the forefront of diabetes diagnostics for over twenty years and created the current generation of home blood glucose testing devices used throughout the world. More recently, the University has been working with Pelikan Technologies in Palo Alto, USA to develop the ultimate painless and convenient system and together they have created the first, fully integrated, blood sampling and glucose measurement device a truly one step procedure.

Now in one of the largest medical device company financings of 2004, Pelikan has announced the closing of a $29.2 million Series D preferred stock financing with several leading international investors. This brings the total financing into the company up to $46.2 million since its founding in 2001.

Pelikan's first product, which is expected to be launched in the spring of 2005, is the Pelikan Sun lancing device. Based on the company's "one-step, one-button" approach, this lancing device is the first fully-automated, electronically-controlled, self-contained system that allows a patient to execute the entire lancing process at the touch of a button in a virtually painless operation. Lancing, an often painful act of piercing the skin in order to obtain a sample of blood for glucose measurement, is required multiple times each day for millions of people with diabetes.

Head of Cranfield University at Silsoe, Professor Tony Turner was intimately involved in the development of this innovative product and said " The device, not only improves the ease of use and convenience for people with diabetes but it also significantly reduces the pain of a procedure that millions of diabetics go through multiple times a day. This is an especially important breakthrough for diabetic children, who often have very sensitive skin."

Proceeds from this financing will be primarily used to support Pelikan's commercialisation of the FDA-cleared Pelikan SunTM lancing device, as w
'"/>

Contact: Helen Meadows
pressoffice@cranfield.ac.uk
44-123-475-4999
Cranfield University
5-Nov-2004


Page: 1 2

Related biology news :

1. Oncolytics Biotech Inc., research collaborators demonstrate reovirus/gemcitabine
2. Indias biotech industry emerging as world innovator, collaborator, competitor
3. EMBL-EBI and collaborators win bid to run UK PubMed Central
4. Carnegie Mellons Peter Adams receives EPA research grant
5. Philadelphia ecologist receives top Mongolia honor
6. VIB scientist receives major research grant
7. Maynard Olson receives $500,000 Gruber Genetics Prize
8. University of Cincinnati receives $1.7M to research molecular treatment of brain injury
9. Wright State scientist receives grant to help clean up polluted American harbors
10. UCR biologist receives $1.75 million grant to study plant-threatening bacteria
11. Michael R. Zalutsky receives SNMs 2007 Paul C. Aebersold Award

Post Your Comments:
(Date:10/31/2014)... New Haven, Conn. – Geologists are letting the air out ... on Earth. , Scientists have long speculated as to why ... Earth,s surface. Animals began to prosper at the end of ... what about the billion-year stretch before that, when most researchers ... seems the air wasn,t so great then, after all. , ...
(Date:10/31/2014)... good for attracting species, but it may not be enough ... study has found. , The researchers surveyed two types of ... abundance of two insects that interact with them. They found ... and black walnut, they didn,t find a corresponding abundance of ... the walnuts and black cherries and a type of wasp ...
(Date:10/31/2014)... Melbourne researchers have uncovered key steps involved in programmed ... diseases including lupus, cancers and neurodegenerative diseases. , ... Institute worked together to discover the three-dimensional structure of ... the first steps in how it causes cell death. ... and Proceedings of the National ...
Breaking Biology News(10 mins):Lack of oxygen delayed the rise of animals on Earth 2Green spaces don't ensure biodiversity in urban areas 2A matter of life and death: Cell death proteins key to fighting disease 2
(Date:10/31/2014)... Brady (NYSE:BRC), a global ... a new video testimonial on the effectiveness ... a research technician at the BloodCenter of Wisconsin discusses ... and storing hundreds of thousands of samples, and how ... , “At Brady, we design our label materials with ...
(Date:10/31/2014)... 2014  Tavistock Development Co. (TDC), a diversified ... groundbreaking of the GuideWell Innovation Center ... The 92,000-square-foot, three-story facility is the first multi-tenant ... designed specifically for life sciences, health innovation, and ... 650-acre Lake Nona Medical City, near the Sanford-Burnham ...
(Date:10/30/2014)... Investor-Edge has initiated coverage on the following ... (NASDAQ: MDVN ), Pharmacyclics Inc. (NASDAQ: ... and Ironwood Pharmaceuticals Inc. (NASDAQ: IRWD). Free research on ... . On Wednesday, October 29, 2014, the ... Jones Industrial Average declined 0.18%, to finish the day ...
(Date:10/30/2014)... Dallas, Texas (PRWEB) October 30, 2014 ... China Naltrexone HCL Industry” is a professional and ... The report provides basic Naltrexone HCL information, including ... as well as industry overview. This research covers ... as well as global industry analysis covering macroeconomic ...
Breaking Biology Technology:Brady Debuts New Lab Label Testimonial Video 2GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 2GuideWell Innovation Center Groundbreaking Hosted by Tavistock Development Company at Lake Nona Medical City 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 2Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 3Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 4Biotech Equities Movers and Shakers - Organovo Holdings, Medivation, Pharmacyclics, Synthetic Biologics, and Ironwood Pharma 5Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 2Naltrexone HCL Market & Nalbuphine HCL Industry Analysis for Global, China Regions Now at DeepResearchReports.com 3
Cached News: